[Catalytic activity of aspartate aminotransferase in erythrocytes in chronic kidney failure]. 1985

M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic

Related Publications

M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
June 1986, Biokhimiia (Moscow, Russia),
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
August 1978, The Journal of biological chemistry,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
July 1979, European journal of biochemistry,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
January 1975, Physiological chemistry and physics,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
April 1983, Clinical biochemistry,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
December 1976, Vnitrni lekarstvi,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
December 1964, Biochimica et biophysica acta,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
September 1981, Clinica chimica acta; international journal of clinical chemistry,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
March 1978, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Mydlík, and K Derzsiová, and M Takác, and T Szabó, and V Dandár
December 1973, European journal of biochemistry,
Copied contents to your clipboard!